DCM
ABMD

Davidson Capital Management’s Abiomed Inc ABMD Stock Holding History

Davidson Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11
Closed -$3K – 160
2022
Q3 		$3K Buy
11
+3
+38% +$810 ﹤0.01% 69
2022
Q2 		$2K Hold
8
– – ﹤0.01% 78
2022
Q1 		$3K Hold
8
– – ﹤0.01% 76
2021
Q4 		$3K Hold
8
– – ﹤0.01% 84
2021
Q3 		$3K Buy
8
+2
+33% +$678 ﹤0.01% 80
2021
Q2 		$2K Sell
6
-3,541
-100% -$1.09M ﹤0.01% 86
2021
Q1 		$1.13M Buy
3,547
+673
+23% +$215K 0.59% 48
2020
Q4 		$932K Buy
2,874
+87
+3% +$24.1K 0.52% 41
2020
Q3 		$772K Sell
2,787
-999
-26% -$288K 0.49% 40
2020
Q2 		$915K Buy
3,786
+209
+6% +$42K 0.81% 27
2020
Q1 		$519K Buy
3,577
+1,723
+93% +$286K 0.74% 40
2019
Q4 		$316K Buy
+1,854
New +$344K 0.25% 44

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Davidson Capital Management's ABMD Position: Q4 2022 in Review

Davidson Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 11 shares — an estimated $3K sold.

Davidson Capital Management first reported a position in ABMD in Q4 2019 and held it in 12 quarters. The position peaked at $1.13M in Q1 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Davidson Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Davidson Capital Management sold 11 Abiomed Inc shares in Q4 2022, an estimated $3K.
  • Davidson Capital Management first reported a position in Abiomed Inc in Q4 2019 and held it in 12 quarters.
  • Davidson Capital Management's Abiomed Inc position peaked at $1.13M in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Davidson Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.